Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Projected Timeline (Estimates, Not Confirmed) Phase 3 completion: Most TRIUMPH trials completing throughout 2026 NDA submission to FDA: Estimated late 2026 (depends on results across the full program) FDA review period: Typically 10-12 months for a standard review Approval decision: Estimated 2027, possibly earlier if Lilly seeks priority review Commercial availability (pharmacies): Several months after approval for manufacturing scale-up GlobalData, a pharmaceutical analytics firm, projects a 2027 approval with forecasted annual sales reaching $15.6 billion by 2031
Consumer Education Gap: Explaining peptide science versus traditional methods is challenging
Priority 2: Resistance training
Others may require you to pay a copay or deductible
The peptide chains remain intact
The peptide upregulates expression of epidermal growth factor, hepatocyte growth factor, and vascular endothelial growth factor among others
US$ 20.55
US$ 26.97
US$ 22.81
